Skip to main navigation Skip to search Skip to main content

Linking MLL and the HGF-MET signaling pathway in liver cancer

Jens U. Marquardt, Snorri S. Thorgeirsson*

*Corresponding author for this work

Abstract

Mixed-lineage leukemia (MLL; also known as myeloid/lymphoid), the human homolog of trithorax in Drosophila, is a transcriptional coactivator that plays an essential role during early development and hematopoiesis. Furthermore, MLL is critically involved in the epigenetic regulation of cell cycle, senescence, DNA damage, and stem cell self-renewal. Chromosomal aberrations of MLL in acute leukemias are well documented, but the role of this gene in solid malignancies remains unclear. In this issue of the JCI, Takeda et al. describe a novel epigenetic link between MLL and the HGF-MET signaling pathway conferring invasive and metastatic properties to hepatocellular carcinoma cells.

Original languageEnglish
JournalJournal of Clinical Investigation
Volume123
Issue number7
Pages (from-to)2780-2783
Number of pages4
ISSN0021-9738
DOIs
Publication statusPublished - 01.07.2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Linking MLL and the HGF-MET signaling pathway in liver cancer'. Together they form a unique fingerprint.

Cite this